The Summer Placements for the Class of 2017-19 of the two-year post graduate programme at IIM Bangalore saw 401 students recruited by 130+ ...

More analysts are getting attracted to this counter because the recent correction has brought down its valuations to reasonably levels.

An ETMarkets.com survey among the brokerages showed most experts expect the benchmark equity indices to move in the 27,000-31,000 range.

Sensex is down about 4,000 points from its record high of 30,025 hit in March, but Calendar 2016 promises to be better for Indian investors.

"Granules India is in the limelight and that has to do with the approval from US FDA "

"On 28th January board meeting directors have approved fundraising plans for Rs 250 crore. We are calling for shareholders meeting on 27th ...

Most of the high beta stocks have more than doubled in the past one year, but analysts feel that there is more upside left in the benchmark...

Granules India, a city-based pharmaceutical manufacturer, said its shareholders have approved proposed acquisition of Auctus Pharma.

Hyderabad-based pharmaceutical firm Granules India has agreed to buy Auctus Pharma for about Rs 100 crore in an all-cash deal.

The acquisition process is expected to be completed in the next 3 to 6 months, a release from Hyderabad-based Granules India said.